Trial Profile
A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Apadenoson (Primary) ; Adenosine
- Indications Coronary disorders
- Focus Diagnostic use
- Sponsors Forest Laboratories
- 03 Jun 2014 New trial record